Clinical Trials Logo
  1. Home
  2. Radiation Therapy
  3. NCT04443400

Early Detection of Cardiac Damage by Two‑Dimensional Speckle Tracking Echocardiography After Thoracic Radiation Therapy

Radiation Therapy Clinical Trial

Official title:
Early Detection of Cardiac Damage by Two‑Dimensional Speckle Tracking Echocardiography After Thoracic Radiation Therapy

Clinical Trial Summary

The purpose of this study is to detecte and predict early subclinical cardiac damage induced by thoracic radiation therapy based on two‑dimensional speckle tracking echocardiography combined with multiple circulating biomarkers.

Clinical Trial Description

This is a monocentric prospective cohort study in which 100 patients treated for malignant tumors and with cardiac radiation exposure will be included.All patient will be followed for 12 months after radiotherapy. Echocardiography, 2D STE parameters and circulating biomarkers will be collected. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04443400
Study type Observational [Patient Registry]
Source Peking University Third Hospital
Contact Dan Zhu, M.D.
Phone +8613810103532
Email andrea_zhu@163.com
Status Recruiting
Phase
Start date January 1, 2020
Completion date December 31, 2021
View Details
See also
  Status Clinical Trial Phase
Completed NCT04324645 - Active Symptom Monitoring in Patients Undergoing Radiation Therapy for Thoracic Malignancies
Completed NCT04776083 - Radiotherapy to the Primary in Metastatic Non-small Cell Lung Cancer Patients Phase 3
Completed NCT01635270 - Phase 2 Study Evaluating Mid-position Strategy in Radiotherapy Treatment for Patients With a Locally Advanced Non-small Cell Lung Carcinoma Phase 2
Terminated NCT03724422 - HO Prophylaxis Therapy for Distal Humerus Fractures N/A
Recruiting NCT03731130 - Prospective Observational Trial to Evaluate Quality of Life After Neoadjuvant Radiation or Chemoradiation Followed by Surgery in Patients With Rectal Cancer
Recruiting NCT04983095 - Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer Phase 3
Recruiting NCT05721053 - Improving Outcomes for Older Adults Undergoing Radiation Therapy
Active, not recruiting NCT04764227 - Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17) Phase 2
Not yet recruiting NCT05821452 - Immunotherapy Plus Chemotherapy vs. Chemoradiotherapy for Thoracic Squamous Esophageal Carcinoma Phase 2
Recruiting NCT05335148 - Study to Evaluate the Safety of Colchicine Phase 1
Recruiting NCT04362306 - Radiation Oncology Patient Medical Physics Intervention Study N/A
Completed NCT01917890 - Radiosensitizing and Radioprotectve Effects of Curcumin in Prostate Cancer N/A
Not yet recruiting NCT05648253 - Hyivy Device in Post-radiation Patients N/A
Completed NCT03235427 - The CAROLE (CArdiac Related Oncologic Late Effects) Study
Recruiting NCT03142425 - Blood Test to Predict Radiation Response and Toxicity in Patients Undergoing Radiation Therapy
Recruiting NCT05406063 - Stereotactic Multiple Fraction Radiotherapy for Non-spine Bone Metastases N/A
Recruiting NCT03213925 - Neoadjuvant Chemotherapy Followed by Radiotherapy Alone in Patients With Breast Cancer Phase 2
Recruiting NCT03071289 - A Trial Comparing Observation With Radiation on Pelvic Lymphocysts After Radical Hysterectomy of Cervical Cancer Phase 3
Recruiting NCT06128863 - Pembrolizumab in Combination With Eftilagimod Alpha and Radiotherapy in Neoadjuvant Treatment of Patients With Soft Tissue Sarcoma - EFTISARC-NEO Trial Phase 2
Recruiting NCT05351294 - Assessment of Early Radiation Oncology Involvement Alongside Standard Oncologic Care in the Managemet Phase 3